Skip to main content

Peer Review reports

From: A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial

Original Submission
15 Jan 2021 Submitted Original manuscript
21 Jan 2021 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
24 Jan 2021 Editorially accepted
5 Feb 2021 Article published 10.1186/s13063-021-05072-4

You can find further information about peer review here.

Back to article page